Identity
What is tirzepatide?
Tirzepatide is a synthetic, acylated peptide analog that activates GIP and GLP-1 receptors. The database identity describes the reference substance.

Peptide research reference
A source-based identity and evidence record for the synthetic, acylated peptide analog also identified by development code LY3298176.
Published by Elevated Pharma ·
Identity
Tirzepatide is a synthetic, acylated peptide analog that activates GIP and GLP-1 receptors. The database identity describes the reference substance.
Research context
Structural and receptor-pharmacology literature examines binding and signaling at GIP and GLP-1 receptors.
Evidence boundary
An FDA-approved prescription product exists. That status does not transfer to an unlabeled research material, supplier source, or other product.
U.S. context
Current FDA prescribing information controls the approved drug product. This informational record is not prescribing information.
Reference identifiers
Primary and official sources
Research questions
The cited structural and pharmacology literature examines signaling at GIP and GLP-1 receptors.
No. Approval and prescribing information apply to the exact approved product. They do not transfer to another source, label, or laboratory material.
It is written for qualified laboratory researchers reviewing identity, terminology, receptor context, and source provenance. It is not prescribing or human-use guidance.
Lot identity requires product-specific labeling, chain-of-custody records, and a matching analytical record. A database identity or prescribing label is not a lot certificate.
Use the exact lot label, safety data, analytical documentation, and an approved institutional protocol. A general reference page cannot establish product-specific handling or storage.